Variant report
Variant | nsv829434 |
---|---|
Chromosome Location | chr2:56812143-56815000 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:56812542..56814077-chr2:56817593..56819138,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72805178 | chr2:56812145-56812146 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs66555858 | chr2:56812161-56812162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs6745039 | chr2:56812187-56812188 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs571511584 | chr2:56812292-56812293 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371660253 | chr2:56812325-56812326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs139449583 | chr2:56812329-56812330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554305877 | chr2:56812418-56812419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569709378 | chr2:56812481-56812482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs190726743 | chr2:56812510-56812511 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs538963047 | chr2:56812537-56812538 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556363536 | chr2:56812541-56812542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116512323 | chr2:56812552-56812553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544932014 | chr2:56812580-56812581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs114213385 | chr2:56812599-56812600 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372715926 | chr2:56812603-56812604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs149325576 | chr2:56812639-56812640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373345188 | chr2:56812687-56812688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs147421098 | chr2:56812696-56812697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560634333 | chr2:56812697-56812698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs529767211 | chr2:56812719-56812720 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192157963 | chr2:56812735-56812736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs184524407 | chr2:56812746-56812747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188320397 | chr2:56812771-56812772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs551742649 | chr2:56812790-56812791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75700843 | chr2:56812798-56812799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs181196703 | chr2:56812799-56812800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs367558973 | chr2:56812802-56812803 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs543907330 | chr2:56812818-56812819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs547848298 | chr2:56812823-56812824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs115966287 | chr2:56812829-56812830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs202131451 | chr2:56812900-56812901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs536706989 | chr2:56812909-56812910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs556625832 | chr2:56812918-56812919 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs534303583 | chr2:56812923-56812924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs576107888 | chr2:56812932-56812933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs554110486 | chr2:56812933-56812934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs139707675 | chr2:56812941-56812942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs56191705 | chr2:56813027-56813028 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs55889936 | chr2:56813037-56813038 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs116813499 | chr2:56813064-56813065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs563918493 | chr2:56813087-56813088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs72805180 | chr2:56813097-56813098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546502258 | chr2:56813160-56813161 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs574110603 | chr2:56813164-56813165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543074805 | chr2:56813197-56813198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs560072060 | chr2:56813218-56813219 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs34664935 | chr2:56813263-56813264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563400576 | chr2:56813272-56813273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs531811033 | chr2:56813310-56813311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188798052 | chr2:56813324-56813325 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56810600-56816000 | Weak transcription | NHEK | skin |
2 | chr2:56810800-56815800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr2:56811400-56814400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
4 | chr2:56811600-56814200 | Weak transcription | HSMM | muscle |
5 | chr2:56811800-56814200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr2:56814200-56814400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
7 | chr2:56814200-56814800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr2:56814200-56815200 | Enhancers | HSMM | muscle |
9 | chr2:56814400-56814800 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr2:56814400-56815800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
11 | chr2:56814800-56816600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr2:56814800-56818000 | Weak transcription | Muscle Satellite Cultured Cells | -- |